S

Saluda Medical

ECAP-guided spinal cord stimulation therapy

Territory Manager

Field SalesConfirmed live in the last 24 hours
Full-timeBaton Rouge, LA, USANo salary listedRemote

About the Job

Requirements

  • At least 5 years of medical device sales experience.
  • Demonstrated track record of new territory growth, new account development, and exceeding quota in a complex capital or implantable device environment.
  • Comfort operating in a clinical setting, including an operating room, procedure suite, or pain clinic, with the ability to support technical programming workflows.
  • Strong scientific acumen and ability to read, interpret, and translate clinical data into customer-facing conversations.
  • Bachelor's degree required.
  • Ability to work effectively without direct daily supervision.

Responsibilities

  • Develop and execute a strategic, comprehensive go-to-market plan to drive revenue growth in the assigned geography.
  • Provide hands-on clinical and technical advisory and support throughout the sales and patient lifecycle.
  • Use clinical evidence as the foundation for the commercial narrative.
  • Identify and develop key opinion leaders within the territory who can amplify Saluda's clinical message at regional and national levels.
  • Collaborate cross-functionally to build tailored programs to reach and educate physicians and patients in the area.
  • Lead the patient journey from education through operating room activities, including trials, implant procedures, and ongoing care.

Desired Qualifications

  • Medical device sales experience in neuromodulation, spinal surgery, or implantable devices is strongly preferred.
  • Background in life sciences, nursing, or allied health is a plus.

About the Company

Saluda Medical

ECAP-guided spinal cord stimulation therapy

Saluda Medical develops neuromodulation therapies for chronic pain by focusing on spinal cord stimulation. Its Evoke System uses Evoked Compound Action Potentials to measure the spinal cord’s response to stimulation and adjusts parameters in real time for each patient. This closed-loop approach relies on objective neural signals rather than fixed settings, aiming for consistent pain relief and personalized therapy, supported by clinical trial data. The company seeks to broaden neuromodulation use by providing precise, measurable neural activation readouts to clinicians.

Company size
501-1,000
Company stage
IPO
Headquarters
Sydney NSW, Australia
Founded
2013

Recently Posted Jobs

Explore more opportunities at Saluda Medical

See more jobs